Pollen K F Yeung
Professor of Pharmacy and Medicine
Dalhousie University, Canada
BURTON M A
Professor, Department of Medicine
Suny Downstate Medical Center, United States
Department of Biochemistry and Molecular Biology, Vascular Biology Center
Georgia Health Sciences University, USA
Submit manuscript at www.walshmedicalmedia.com/submissions/cardiovascular-pharmacology.html or send as an e-mail attachment to the Editorial Office at [email protected]
Index Copernicus Value:: 62.49
NLM ID: 101664844
Cardiovascular Pharmacology: Open Access Journal has an increasing role in diagnosis, characterization, therapy of various marked diseases in the field of Cardiovascular Pharmacology. The journal aims to promote international dialogue and collaboration on health issues to improve clinical practice and to expand and deepen the understanding of health and health care.
The journal includes a wide range of fields that mainly deals with Angina, Stroke, and all Heart diseases and its pharmacology related to all living organisms.
Cardiovascular Pharmacology: Open Access is a journal that aims to publish the most complete and reliable source of information on the discoveries and current developments as original articles, review articles, case reports, short communications, etc. in all areas of the field and make them available online to the researchers worldwide without any subscriptions.
The Journal provides a unique forum dedicated to scientists to express their research on a wide array of Cardiovascular Pharmacology topics. The Cardiovascular Pharmacology: Open Access Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Cardiovascular Pharmacology: Open Access journal impact factor is mainly calculated based on the number of articles published and cited in a given year.
Classification Keywords: Cardiovascular, Cardiovascular System, Cardiomyopathy, Preventive Cardiology, Pulmonary Hypertension, Heart Block, Blood Pressure, Hypertension, Cardiothoracic Surgery, Stroke, Echocardiography, Heart Failure, Pediatric and Congenital Cardiology, Congenital Heart Defects, Electrophysiology, Cardiothoracic Surgeons, Stress Test, Pulmonary Atresia, Arrhythmia, Congenital Heart Disease, Hypercholesterolemia, Heart Regeneration/Repair, Vascular Responsiveness, Vascular Medicine, Hematology, Atherosclerosis, Valve Surgery, Diabetes Mellitus, Aortic Surgery, Intravascular Ultrasound, Valve Sparing Root Replacement.
Fast Editorial Execution and Review Process (FEE-Review Process):
Cardiovascular Pharmacology: Open Access is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Cardiovascular Pharmacology: Open Access have been cited by esteemed scholars and scientists all around the world. Cardiovascular Pharmacology: Open Access has got h-index 6 , which means every article in Cardiovascular Pharmacology: Open Access has got 6 average citations.